Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dementia

• Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
• Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
• Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
• Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
• Clinical Study of GKT in Diabetes Related Dementia
• Study in Subjects With Mild-to-Moderate Alzheimer's Dementia
• Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
• Nabilone for Agitation in Frontotemporal Dementia
• Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)
• Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
• Life's End Benefits of Cannabidiol and Tetrahydrocannabinol
• Technical R&D and Demonstration of Intelligent Medical Care in Alzheimer's Disease's Management
• A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
• Dronabinol for Agitation in Dementia Crossover Trial
• Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)
• δ in Dementia Clinical Trials
• Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
• Efficacy Biomarkers of DAOIB for Dementia
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
• IGC-AD1 Trial on Agitation in Dementia Due to AD
• RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease Dementia
• A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
• MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva
• A Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Participants With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) or Mild Alzheimer's Disease Dementia
• Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
• Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia
• Assess Fibrin in Brains With AD/ADRD
• Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
• The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia
• An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
• Dexmedetomidine in the Treatment of Agitation Associated With Dementia
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
• Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
• Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
• NMDA Enhancement Combined With Omega-3 for Early Dementia
• A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
• Sirtuin-NAD Activator in Alzheimer's Disease
• The Dose Finding Study of DAOIB Added to tDCS for AD
• A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD
• A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
• Open-Label Safety Study of AXS-05 in Subjects With Alzheimer's Disease Agitation
• Dopaminergic Therapy for Frontotemporal Dementia Patients
• Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)
• ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation
• Fasudil fOr redUcing elopemeNt and Spatial Disorientation
• Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia
• A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology
• Terazosin for Dementia With Lewy Bodies
• Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease
• A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN)
• A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders
• DAOIB Combined With tDCS for Early-phase Dementia
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
• A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
• Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
• OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001
• Prospecta in the Treatment of Cognitive, Behavioural and Psychiatric Disorders in Patients With Vascular Dementia.
• The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
• A Translational Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
• ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
• Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
• Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
• Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
• Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• Phase 1/2 Clinical Trial of PR006 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
• Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
• PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
• A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)
• Amisulpride Treatment for BPSD in AD Patients
• To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia
• The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy
• Vortioxetine in Patients With Depression and Early Dementia
• Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
• A Noval Tau Tracer in Young Onset Dementia
• NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
• Monitoring Anti-Dementia Drugs by Serum Levels
• Intranasal Insulin in Frontotemporal Dementia (FTD)
• Metformin in Alzheimer's Dementia Prevention
• Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia
• A Study to Determine the Metabolism and Elimination of [14C]E2027 in Healthy Male Participants
• Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
• Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
• K0706 for Patients Diagnosed With Dementia With Lewy Bodies
• A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)
• Local Study of Akatinol Memantine in VaD in Russia
• PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel TSPO Radioligand
• A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia
• Trial of Parkinson's And Zoledronic Acid
• The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia
• Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)
• Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies
• Treating Hyperexcitability in AD With Levetiracetam
• A Study to Assess Safety, Tolerability, Pharmacodynamics, Immunogenicity, Exploratory Clinical Efficacy, and Pharmacokinetics of Intravenous Infusions of E2814 in Healthy Participants and Participants With Prodromal Alzheimer's Disease (AD) to Moder
• The Efficacy of Traditional Chinese Herbal Medicine for Dementia
• Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
• A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.
• Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
• Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
• The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule
• Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
• Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-study
• ANAVEX2-73 Study in Parkinson's Disease Dementia
• Deferiprone for Ruptured Brain Aneurysm
• Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
• Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
• Interventions for Patients With Alzheimer's Disease and Dysphagia
• The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women
• A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalit
• 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls
• Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
• 18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia
• A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
• A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies
• 11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes
• A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
• A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
• Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
• Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Participants With Dementia With Lewy Bodies
• A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease
• Feru-guard for Behavioral Symptoms in Dementia
• Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia
• Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Healthy Volunteers
• To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• The Effect of Cannabis on Dementia Related Agitation and Aggression
• Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
• Memory and Antioxidants in Vascular Impairment Trial
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
• Tau PET Imaging in Atypical Dementias
• Intranasal Oxytocin for Frontotemporal Dementia
• Deferiprone to Delay Dementia (The 3D Study)
• Efficacy and Safety of TMBCZG in Mild to Moderate Vascular Dementia
• Addressing Dementia Via Agitation-Centered Evaluation
• Prazosin and CSF Biomarkers in mTBI
• The Role of Aromatherapy With Lavender Oil in the Long-term Care on a Patients Behavioral Problems Associated With Dementia
• Intranasal Insulin for the Treatment of HAND
• Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
• Flortaucipir PET Imaging in Subjects With FTD
• Study of Mirtazapine for Agitation in Dementia
• TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
• Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia
• The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND
• A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
• A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
• Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome
• CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
• Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease
• Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
• Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias
• Ambroxol as a Treatment for Parkinson's Disease Dementia
• Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
• A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia
• Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
• Low-Dose Lithium for the Treatment of Behavioral Symptoms in Frontotemporal Dementia
• CPC-201 Alzheimer's Disease Type Dementia: PET Study
• The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression
• Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease
• ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
• A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
• The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery
• Implications for Management of PET Amyloid Classification Technology
• A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)
• F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
• Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
• Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
• Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
• Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
• Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study
• Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
• A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease
• Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
• An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia
• Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer
• A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
• Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies
• Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals
• International Substudy Enigma2 on Postoperative Cognitive Disorders
• BAC in Patient With Alzheimer's Disease or Vascular Dementia
• Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia
• Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial
• Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
• Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
• Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07
• The Efficacy and Safety Study of High Dose Donepezil in Parkinson's Disease With Dementia
• Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia.
• Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction
• Pharmacovigilance in Gerontopsychiatric Patients
• Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia
• Investigating the Clinical Consequences of Flutemetamol-PET-scanning
• Apathy in Dementia Methylphenidate Trial 2
• A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
• Ramelteon in the Prevention of Post-operative Delirium
• Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease
• Tau Imaging in Young Onset Dementia
• Nilotinib in Cognitively Impaired Parkinson Disease Patients 001
• Move for Your Mind - Pilot Trial
• Efficacy of Pain Treatment on Depression in Patients With Dementia
• Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
• SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
• Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type
• Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
• Cholinesterase Inhibitor Discontinuation
• Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
• Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
• Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
• Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness
• The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
• A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia
• Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
• Maraviroc and NeuroAIDS Pathogenesis
• Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
• Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
• Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine
• Effect of Cenicriviroc on HIV Neurocognitive Impairment
• Therapy in Amyotrophic Lateral Sclerosis (TAME)
• Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
• DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia
• Symptomatic Treatment of Vascular Cognitive Impairment
• 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
• Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
• Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
• Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
• The Clinical Trial of Chinese Herbal Medicine SaiLuoTong Capsule
• Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
• Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
• Effect of Insulin Sensitizer Metformin on AD Biomarkers
• n-3 PUFA for Vascular Cognitive Aging
• Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly
• Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia
• A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
• Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
• Inhalational Anesthesia and Precipitation of Dementia: is There a Link?
• Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
• A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation
• Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease
• Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
• Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)
• A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
• Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Pro
• Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
• PiB PET Scanning in Speech and Language Based Dementias
• Delta-THC in Dementia
• Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
• Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
• A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
• Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
• Serotonin Transporter Density in Late-life Depression With and Without Dementia
• Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
• Mirtazapine in Alzheimer-associated Weight Loss
• A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)
• Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
• Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)
• Effect of Zydena (Udenafil) on Cerebral Blood Flow and Peripheral Blood Viscosity
• Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
• DaTSCAN Imaging in Aging and Neurodegenerative Disease
• Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
• Roflumilast and Cognition
• A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
• Cilostazol Augmentation Study in Dementia
• A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
• Safety Study of Intranasal Oxytocin in Frontotemporal Dementia
• The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia
• Comparative Research of Alzheimer's Disease Drugs
• Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
• Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
• Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
• Delta-THC in Behavioral Disturbances in Dementia
• A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
• A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia
• Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
• Modulation of Monocyte Activation by Atorvastatin in HIV Infection
• Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
• An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia
• Long-term Outcome of General Anesthesia on Dysgnosia
• Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
• Apathy in Dementia Methylphenidate Trial (ADMET)
• EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010)
• A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
• Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
• Bupropion for the Treatment of Apathy in Alzheimer's Dementia
• Aspirin in Reducing Events in the Elderly
• Characteristics of Treatment Responders to Galantamine
• Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
• "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
• Clinical Trial of Donepezil Between the Naive Group and the Switching Group
• Pain in Patients With Dementia and Behavioural Disturbances
• Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
• Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
• Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
• Oxytocin and Social Cognition in Frontotemporal Dementia
• The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
• Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
• Imaging of Brain Amyloid Plaques in the Aging Population
• Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
• A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
• Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)
• Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon
• Non-Interventional Study With Aricept® Evess
• BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
• A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)
• Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
• Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
• Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia
• The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
• Zolpidem CR and Hospitalized Patients With Dementia
• Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
• Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
• Corticolimbic Degeneration and Treatment of Dementia
• Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
• The Women's Health Initiative Memory Study (The WHIMS Study)
• Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
• The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
• Seroquel- Agitation Associated With Dementia
• Effects of Tolcapone on Frontotemporal Dementia
• A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
• Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia
• Dementia Antipsychotics And Antidepressants Discontinuation Study
• Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
• A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
• Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
• TRx0014 in Patients With Mild or Moderate Alzheimer's Disease
• Postanesthesia Cognitive Recovery and Neuropsychologic Complications
• Memantine Versus Donepezil in Early Stages of Alzheimer's Disease
• Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients
• Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
• Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
• An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.
• Development of NIC5-15 in the Treatment of Alzheimer's Disease
• PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
• Aricept to Improve Functional Tasks in Vascular Dementia
• Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
• A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
• Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
• Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
• Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
• Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients
• Memantine for Agitation in Dementia
• Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
• A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
• Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
• Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
• Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
• An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period
• Memantine for Treatment of Cognitive Impairment in Patients With Parkinson's Disease and Dementia
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
• A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
• A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
• Escitalopram Treatment of Patients With Agitated Dementia
• Apathy Associated With Alzheimer's Disease
• A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
• Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
• A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
• A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
• A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia
• Side Effects of Newer Antipsychotics in Older Adults
• Treatment With Namenda in Women at Risk for Cognitive Decline
• Memantine and Down's Syndrome
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
• Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia
• Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
• The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
• A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
• Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly
• Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
• A Comparison of Two Standard Therapies in the Management of Dementia With Agitation
• Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
• Study of Depakote for Behavioral and Psychological Symptoms in Dementia
• Donepezil Treatment of Psychotic Symptoms in Dementia Patients
• Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
• Antidepressant Medication Plus Donepezil for Treating Late-life Depression
• Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
• The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia
• Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia
• Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
• The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.
• Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
• Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease
• An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type
• The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)
• Rivastigmine Capsules in Patients With Probable Vascular Dementia
• Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
• Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)
• Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
• 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
• Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
• Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
• Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease
• Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
• Treating Behavioral Disturbances in Individuals With Dementia
• Delaying Alzheimer Disease Symptoms With Anti-Inflammatory Drugs
• Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)
• A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
• Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
• Donepezil to Treat Dementia in Parkinson's Disease
• Specific Interventions for Agitation in Alzheimer's Disease
• Pain Management and Behavioral Outcomes in Patients With Dementia
• Preventing Cognitive Decline With Alternative Therapies
• Ginkgo Biloba Prevention Trial in Older Individuals
• Serotonergic Pharmacotherapy for Agitation of Dementia
• A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
• Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy
• A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex
• A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
• Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
• A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases
• Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD)
• Treatment of Alzheimer's Disease With CX516 (Ampalex)
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
• Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
• An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts
• A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
• Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex